7.28
Dariohealth Corp stock is traded at $7.28, with a volume of 60,987.
It is up +7.85% in the last 24 hours and down -4.84% over the past month.
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. The company vertically integrated a health intelligence platform with a mission to power the behavior changes that drive greater health. Unlike software-only digital health platforms, Dario owns the complete chain of value in chronic care management - connected FDA-cleared hardware devices that generate continuous physiological data, and AI built on that proprietary data. The company focuses on delivering user experiences, longer sustained engagement, and stronger clinical outcomes, at affordable prices, which then delivers the highest return on investment in the industry.
See More
Previous Close:
$6.75
Open:
$6.895
24h Volume:
60,987
Relative Volume:
5.27
Market Cap:
$53.23M
Revenue:
$22.36M
Net Income/Loss:
$-33.61M
P/E Ratio:
-0.7565
EPS:
-9.6235
Net Cash Flow:
$-26.08M
1W Performance:
+18.37%
1M Performance:
-4.84%
6M Performance:
-30.80%
1Y Performance:
-48.74%
Dariohealth Corp Stock (DRIO) Company Profile
Name
Dariohealth Corp
Sector
Industry
Phone
972-4-770-6377
Address
322 W 57TH ST. #33B, NEW YORK
Compare DRIO vs VEEV, BTSG, TEM, HQY, HNGE
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
DRIO
Dariohealth Corp
|
7.28 | 48.26M | 22.36M | -33.61M | -26.08M | -9.6235 |
|
VEEV
Veeva Systems Inc
|
192.74 | 28.83B | 3.32B | 941.65M | 1.64B | 5.6161 |
|
BTSG
Brightspring Health Services Inc
|
69.03 | 13.69B | 13.65B | 169.86M | 412.12M | 1.0758 |
|
TEM
Tempus Ai Inc
|
60.27 | 10.40B | 1.36B | -302.91M | -219.93M | -1.7182 |
|
HQY
Healthequity Inc
|
95.31 | 7.55B | 1.34B | 230.70M | 440.96M | 2.6695 |
|
HNGE
Hinge Health Inc
|
84.05 | 6.42B | 646.34M | -512.40M | 202.76M | -6.6871 |
Dariohealth Corp Stock (DRIO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-29-25 | Downgrade | TD Cowen | Buy → Hold |
| May-13-22 | Upgrade | Alliance Global Partners | Neutral → Buy |
| Apr-22-21 | Initiated | Cowen | Outperform |
| Mar-23-21 | Initiated | Stifel | Buy |
| Feb-25-21 | Initiated | Cantor Fitzgerald | Overweight |
| Feb-01-21 | Downgrade | Alliance Global Partners | Buy → Neutral |
| Aug-17-20 | Initiated | Aegis Capital | Buy |
| Aug-29-17 | Initiated | Aegis Capital | Buy |
| May-09-16 | Initiated | Rodman & Renshaw | Buy |
View All
Dariohealth Corp Stock (DRIO) Latest News
DarioHealth (DRIO) Expands Reach via Beluga Health Deal - Streetwise Reports
Digital Health Pioneer Targets Massive Breakthrough Chronic Care Market - Streetwise Reports
DarioHealth adds former Humana compliance chief to board - Investing.com
DarioHealth Adds Former Humana Compliance Chief Sean O’Reilly to Advisory Board - citybiz
DarioHealth adds former Humana compliance chief to board By Investing.com - Investing.com Nigeria
DarioHealth taps ex-Humana compliance chief for advisory board - Stock Titan
DarioHealth signs collaboration agreement with Beluga Health - MSN
DarioHealth Corp.(NasdaqCM: DRIO) added to Russell Microcap Value Benchmark Index - marketscreener.com
Dario Announces Strategic Collaboration with Beluga Health to Deliver Provider-Backed, Integrated Care at Scale - PR Newswire
DarioHealth Corp.(NasdaqCM: DRIO) added to Russell 3000E Index - marketscreener.com
DarioHealth Corp.(NasdaqCM: DRIO) added to Russell Microcap Index - marketscreener.com
DarioHealth Corp. (DRIO) Surges 14% on Heavy Volume – Key Levels to WatchNHNL Divergence - dars.gov.et
DarioHealth Corp. Actuals & Estimates (NASDAQ:DRIO) - TradingView
DRIO Forecast — Price Target — Prediction for 2027 - TradingView
DarioHealth: Chronic Care Platform Drives Value - Streetwise Reports
DarioHealth Corp. (DRIO) reports Q1 loss, beats revenue estimates - MSN
Four New ADA Studies Reveal Clinical Wins in Weight Blood Sugar & Healthcare Utilization - Streetwise Reports
DarioHealth Corp (DRIO) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
DarioHealth Corp (DRIO) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
DarioHealth Corp (DRIO) Institutional Confidence - TradingKey
DarioHealth Corp (DRIO) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
DarioHealth (DRIO) upgraded to buy: Here's why - MSN
DarioHealth Corp (DRIO) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
DarioHealth Corp (DRIO) Valuation: PE, PB & Fair Value Analysis - TradingKey
DarioHealth Corp (DRIO) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
DarioHealth Corp (DRIO) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
DarioHealth Corp (DRIO) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
DarioHealth (DRIO) Upgraded to Buy: Here's Why - sharewise.com
DRIO Q1 2026 Earnings: Narrower Loss Beats Estimates; Stock Declines Post-ReleaseEarnings Cycle Outlook - dars.gov.et
DarioHealth (DRIO) Holds Steady Near Resistance as Traders Weigh FundamentalsMomentum ETF - dars.gov.et
DarioHealth Corp stock (US23209T1051): Digital health player after recent earnings update in focus - AD HOC NEWS
Dario Presents Four Studies at American Diabetes Association Scientific Sessions Highlighting Commercial and Clinical Value of its Digital Health Platform - Barchart.com
DRIO Q1 2026 Earnings: Surprise EPS Beat Amid Revenue UncertaintyProfit Growth Outlook - newsline.com
DRIO Q1 2026 Earnings: Narrower-than-Expected Loss Signals Cost DisciplineEarnings Volatility Report - dars.gov.et
DarioHealth Slides 1.9% as Shares Test Support Zone (DRIO)PCR Divergence - dars.gov.et
DarioHealth Corp. (DRIO) Surges Over 5% as Digital Health Stock Tests Key ResistanceBuffered ETF - newsline.com
DarioHealth (DRIO) Sheds 1.16% as Stock Tests Key Support LevelsDeath Cross - The Legal Advocate
DarioHealth Expands Hypertension Program, Reaching Over 500,000 Eligible Lives Through Solera Health - geneonline.com
Dario More Than Doubles Addressable Market in Solera Health's Network via Expanded Hypertension Program, With Dario Now Reaching Greater Than 500,000 Eligible Lives - PR Newswire
Hypertension digital program deal lets DarioHealth reach 500,000 people - Stock Titan
DarioHealth (DRIO) heads into long weekend with caution flag up - Bez Kabli
DarioHealth Corp. (DRIO) Rallies 4.11%, Testing Key Resistance at $8.25Trade Idea Marketplace - Newser
DarioHealth Corp stock (US23725P3082): reverse split and digital health ambitions in focus - AD HOC NEWS
DarioHealth Announces $25.6M Private Placement Positioning the C - GuruFocus
DarioHealth Corp stock (US23209T1051): earnings miss keeps digital health share under pressure - AD HOC NEWS
DarioHealth (DRIO) Delivers Q1 2026 Beat — EPS $-1.25 vs $-1.51 ExpectedCommunity Buy Alerts - Newser
Encompass Health to expand Idaho presence with new 50-bed facility - MSN
TradingKey - TradingKey
DarioHealth Corp. (DRIO) reports Q4 loss, beats revenue estimates - MSN
DarioHealth Corp. (NASDAQ:DRIO) Q1 2026 Earnings Call Transcript - Insider Monkey
New York Digital Health Firm Expands Reach to 116 Million Covered Lives - Streetwise Reports
Dariohealth Corp Stock (DRIO) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):